The aspergillosis treatment market size is expected to see strong growth in the next few years. It will grow to $3.98 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to demand for transplant medicine, prevalence of hematologic malignancies, increasing investments in research and development, public health initiatives. Major trends in the forecast period include antifungal resistance, targeted therapies, therapeutic drug monitoring, drug development.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/aspergillosis-treatment-global-market-report
Segmentation & Regional Insights
The aspergillosis treatment market covered in this report is segmented –
1) By Type: Allergic Aspergillosis; Chronic Aspergillosis; Invasive Aspergillosis; Other Type
2) By Drug Class: Corticosteroids; Antifungal drugs; Other Drug Class
3) By Route of Administration: Oral; Injectable; Other Route Of Administration
4) By Distribution Channel: Hospital pharmacies; Retail pharmacies; Other Distribution Channel
North America was the largest region in the aspergillosis treatment market in 2023. The regions covered in aspergillosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12987&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of fungal infections is expected to propel the growth of the aspergillosis treatment market going forward. Fungal infections, also known as mycosis, are diseases caused by fungi. It can also cause infections in humans and animals. Aspergillosis is a fungal infection that affects various body parts, including the respiratory system, lungs, brain, kidneys and other organs. Aspergillosis treatment, such as voriconazole, aims to control the fungal infection, alleviate symptoms, prevent complications and improve overall health. For instance, in July 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, fungal hospitalization rates increased from 22.3 in 2019 to 25.0 in 2020 and 26.8 in 2021, a rise of an average of 8.5% annually per 10,000 hospitalizations. Therefore, the increasing prevalence of fungal infections is driving the growth of the aspergillosis treatment market.
Key Industry Players
Major players in the aspergillosis treatment market are Basilea Pharmaceutica Ltd., Pfizer Inc., Johnson and Johnson, AbbVie Inc., Bayer AG, Novartis AG, Merck and Co. Inc., Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries, Astellas Pharma Inc., Regeneron Pharmaceuticals, Mylan N.V. , Sun Pharmaceutical Industries, Jazz Pharmaceuticals, Dr. Reddy's Laboratories, Cipla Ltd., Bruker Corporation, Hikma Pharmaceuticals PLC.
The aspergillosis treatment market report table of contents includes:
1. Executive Summary
2. Aspergillosis Treatment Market Characteristics
3. Aspergillosis Treatment Market Trends And Strategies
4. Aspergillosis Treatment Market – Macro Economic Scenario
5. Global Aspergillosis Treatment Market Size and Growth
………………..
31. Aspergillosis Treatment Market Other Major And Innovative Companies
32. Global Aspergillosis Treatment Market Competitive Benchmarking
33. Global Aspergillosis Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Aspergillosis Treatment Market
35. Aspergillosis Treatment Market Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
https://goodprnews.com/mortar-mixing-equipment-global-market-size/
https://goodprnews.com/oral-cancer-treatment-global-market-size/
https://goodprnews.com/osimertinib-drugs-global-market-share/
https://topprnews.com/mortar-mixing-equipment-global-market-share/
https://topprnews.com/oral-cancer-treatment-global-market-share/
https://topprnews.com/osimertinib-drugs-global-market-size/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
